Skip to main content
Top Header menu
About us
ALB D&I
Advertisement
Contact Us
Log in
search
Asia
China
India
Admin
Main navigation
News
Breaking News
Appointments
Deals
In House News
Other News
Features and Analysis
News By Jurisdiction
Expert commentary
E-Magazines
E-Magazine Archive
Events
In-House Summits
Law Awards
Masterclasses
Partner Events
Forums & Conferences
Find A Firm
Legal Jobs
Virtual Events
Videos
Rankings & Research
Listing
Handbooks
ALB HONG KONG IPO HANDBOOK 2020
ALB ASIA INSOLVENCY & RESTRUCTURING HANDBOOK 2020
ALB LEGAL GUIDE TO THE GREATER BAY AREA 2021
ALB GUIDE TO SHANGHAI STAR MARKET IPOs 2021
Subscribe
Menu
News
Events
E-Magazines
Find A Firm
Legal Jobs
Rankings & Research
Listing
Virtual Events
videos
handbooks
subscribe
盛德助力康方生物签署50亿美元合作许可协议(ZH/EN)
BY Charlie Wu 吴卓言 |
13 Dec 22
近日,总部位于中国的生物制药上市公司康方生物与 总部位于美国加利福尼亚的生物制药上市公司Summit Therapeutics Inc. 签署了一项交易总金额有望高达50亿美元合作许可协议。盛德律师事务所为康方生物提供了全程的法律服务。